Dr. Michael Andrew Samuels, MD

Dr. Samuels practices at Banner Thunderbird Medical Center in Glendale, Arizona, part of Banner Health.

Dr. Samuels' NPI, 1235103425, was assigned on February 14, 2006. Dr. Samuels graduated from Tufts University School Of Medicine in 1988. Dr. Samuels holds Arizona license 64298.

Dr. Samuels' primary practice is Banner Thunderbird Medical Center, at 5555 West Thunderbird Road, Glendale, AZ 85306 in Maricopa County. The practice phone is (602) 865-4470.

Dr. Samuels' primary practice is Banner Thunderbird Medical Center in Glendale, Arizona, part of Banner Health. Dr. Samuels is also affiliated with Banner - University Medical Center Phoenix. The medical group on file is Banner Cancer Center Specialists LLC. Dmand AI also links Dr. Samuels to 2 more hospitals and 1 medical group, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Samuels practices, 4 sites in all. Vendor and product names are available with a free account.

Radiation oncology is Dr. Samuels' primary specialty in the NPI Registry, under taxonomy code 2085R0001X. Dr. Samuels is board certified in radiation oncology by the American Board of Radiology. Dmand AI has Dr. Samuels' licenses on file in 3 states: Arizona, Florida and Ohio.

Dmand AI lists head & neck cancer radiation among the conditions Dr. Samuels treats.

CMS data shows 971 Medicare services from Dr. Samuels across 14 procedure codes in 2024, for 139 Medicare patients. Medicare paid $67,245 for them. Every service was in a facility, such as a hospital, rather than an office.

CMS counts 139 Medicare patients who saw Dr. Samuels in 2024. The largest group is 75 to 84, with 64 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 9% are also on Medicaid. Their average risk score is 1.88, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Samuels' median patient age at 68, with 34% women.

In 2024, Dr. Samuels wrote 78 Medicare Part D claims for 37 patients. 85% of them were for generic drugs. CMS names the drug for 13 of them, across 1 drug with 11 or more claims each, at $124 in total drug cost. In 2022, CMS named 18 claims across 1 drug.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 78 out of 100 for Dr. Samuels for performance year 2024, reported as part of a group. Dr. Samuels accepts Medicare assignment, so Medicare's approved amount is taken as full payment.

Dmand AI links 32 papers to Dr. Samuels, published from 2013 to 2024. 2021 was the busiest year, with 4. The most frequent topics are Head and Neck Neoplasms, Antineoplastic Combined Chemotherapy Protocols and Lung Neoplasms. Dr. Samuels has published most often in Head Neck. Dr. Samuels' most frequent co-authors are Stuart E. Samuels, MD, PhD, Nagy Elsayyad, MBCHB, MD and Laura M. Freedman, MD.

Dmand AI links Dr. Samuels to 1 clinical trial. 1 is still active or recruiting. Conditions studied include Tongue Neoplasms and Tongue Diseases.

CMS Open Payments shows 13 general payments to Dr. Samuels from 6 drug and device companies from 2016 to 2025. Consulting fees make up the largest share, 91% of the total. EMD Serono, Inc. paid the most, $6,454.

Dmand AI lists 3 awards for Dr. Samuels, most recently CMS Stage 1 EHR in 2013.

Dr. Samuels graduated from Tufts University School Of Medicine in 1988. Dr. Samuels is a member of ACR and ASTRO.

Dr. Samuels is in network with 15 carriers, including Aetna, Elevance and United Healthcare. HMO plans come from the most carriers, 9. Check the plan with the practice before a visit.